Bio

Tom has worked in advisory, investing, and operating roles within the healthcare industry for over 20 years, focusing on medical products, medical technology, and diagnostics companies. Tom currently serves as CFO of NanoString Technologies (NASDAQ: NSTG), a provider of life science tools for translational research and molecular diagnostics. Previously, Tom served as the CFO for AgaMatrix, an FFC portfolio company, where he is currently a member of the board of directors.